Related Experiment Video
Updated: Jun 18, 2026
05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
[Ophthalmology]
1Department of Ophthalmology, Tokyo Women's Medical University, School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 11, 2009
Summary
Allergic conjunctival diseases, like seasonal allergic conjunctivitis and vernal keratoconjunctivitis (VKC), are treated with ophthalmic solutions. Combining anti-allergic, steroid, and immunomodulator eye drops offers a safe and effective option for severe VKC.
Area of Science:
- Ophthalmology
- Allergology
- Immunology
Context:
- Allergic conjunctival diseases encompass various subtypes, including seasonal allergic conjunctivitis and vernal keratoconjunctivitis (VKC).
- Current treatments for seasonal allergic conjunctivitis involve anti-allergic solutions, mast cell stabilizers, and H1 blockers, with topical steroids used during peak pollen seasons.
- Topical steroids are effective for VKC but carry risks like increased intraocular pressure.
Purpose:
- To review current treatment strategies for allergic conjunctival diseases.
- To evaluate the efficacy and safety of a combination therapy for severe VKC.
Summary:
- Seasonal allergic conjunctivitis and VKC are common allergic eye conditions.
- Standard treatments include anti-allergic solutions, mast cell stabilizers, H1 blockers, and topical steroids.
- A novel approach combining anti-allergic solution, steroid solution, and topical immunomodulators (cyclosporine or tacrolimus) demonstrates high effectiveness and safety in managing severe VKC.
Impact:
- Provides insights into managing allergic eye diseases.
- Highlights a promising therapeutic strategy for severe VKC.
- Informs clinical practice regarding safe and effective treatment options for allergic conjunctivitis.
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:17Accessory Structures of the Eye
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...